Good News for ME!

In it's phase 2 trial in Norway, the anti cancer drug Rituximab appears to have delivered markedly positive outcomes in as many as two thirds of cases. This offers hope both those of us who have the enigmatic, and to-date incurable, neurological condition ME/CFS (aka ‘M.E.', ‘CFS', ‘SEID'). It also further underscores the belief held by researchers such as myself that the condition may be linked to insidious self-harming effects of certain immune agents (B-lymphocytes and their CNS glial equivalents)

Having said all of that, trials elsewhere are not all finding the drug to be terribly effective, particularly once maintenance doses are stopped

Link: ME Association news item